[1]Journaloflabelledcompoundsandradiopharmaceuticals,2009,vol.52,p.360-365
[2]Patent:CN106047338,2018,B.Locationinpatent:Paragraph0038;0055;0056
[3]AngewandteChemie-InternationalEdition,2013,vol.52,p.8551-8556 Angew.Chem.,2013,vol.125,p.8713-8718,6
[4]JournaloftheAmericanChemicalSociety,2018,vol.140,p.5882-5885
[5]Patent:CN109293638,2019,A.Locationinpatent:Paragraph0014;0015
[6]Patent:CN109485639,2019,A.Locationinpatent:Paragraph0032;0051;0053;0062;0068;0070
[1]AngewandteChemie-InternationalEdition,2013,vol.52,p.8551-8556 Angew.Chem.,2013,vol.125,p.8713-8718,6
[1]CurrentPatentAssignee:DANA-FARBERCANCERINSTITUTE-WO2018/98280,2018,A1Locationinpatent:Page/Pagecolumn149
Title: Virtual screening and further development of novel ALK inhibitors.
Journal: Bioorganic & medicinal chemistry 20110515